Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1

[1]  S. Sachdev,et al.  Role of the fetal and α/β exons in the function of fast skeletal troponin T isoforms : Correlation with altered Ca2+ regulation associated with development , 2005 .

[2]  Susan C. Brown,et al.  Glycosylation eases muscular dystrophy , 2004, Nature Medicine.

[3]  D. Cooper,et al.  Facioscapulohumeral Muscular Dystrophy : Clinical Medicine and Molecular Cell Biology , 2004 .

[4]  G. Dreyfuss,et al.  The SMN complex. , 2004, Experimental cell research.

[5]  L. Ranum,et al.  Myotonic dystrophy: RNA pathogenesis comes into focus. , 2004, American journal of human genetics.

[6]  J. Onderwater,et al.  FRG1P is localised in the nucleolus, Cajal bodies, and speckles , 2004, Journal of Medical Genetics.

[7]  J. Castle,et al.  Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays , 2003, Science.

[8]  W. Hauswirth,et al.  A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.

[9]  D. Cooper,et al.  D4F104S1 deletion in facioscapulohumeral muscular dystrophy , 2003, Neurology.

[10]  L. Kunkel,et al.  Muscular dystrophies: genes to pathogenesis. , 2003, Current opinion in genetics & development.

[11]  J. Mandel,et al.  Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. , 2002, Human molecular genetics.

[12]  Michael R. Green,et al.  Inappropriate Gene Activation in FSHD A Repressor Complex Binds a Chromosomal Repeat Deleted in Dystrophic Muscle , 2002, Cell.

[13]  M. Mann,et al.  Large-scale Proteomic Analysis of the Human Spliceosome References , 2006 .

[14]  K. Campbell,et al.  Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. , 2002, Current opinion in genetics & development.

[15]  Joshua M. Stuart,et al.  A Gene Expression Map for Caenorhabditis elegans , 2001, Science.

[16]  J. Faulkner,et al.  Force and power output of fast and slow skeletal muscles from mdx mice 6‐28 months old , 2001, The Journal of physiology.

[17]  B. Brais,et al.  Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. , 2000, Human molecular genetics.

[18]  J. Mendell,et al.  Definitive molecular diagnosis of facioscapulohumeral dystrophy , 1999, Neurology.

[19]  F. Mangiola,et al.  Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype , 1999, Annals of neurology.

[20]  J. Sanes,et al.  Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.

[21]  Susan C. Brown,et al.  Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.

[22]  R. Tupler,et al.  Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. , 1996, Journal of medical genetics.

[23]  R. Abresch,et al.  Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.

[24]  J E Hewitt,et al.  FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. , 1993, Human molecular genetics.

[25]  L. Kedes,et al.  Multiple 5'-flanking regions of the human alpha-skeletal actin gene synergistically modulate muscle-specific expression , 1987, Molecular and cellular biology.

[26]  S. Sachdev,et al.  Role of the fetal and alpha/beta exons in the function of fast skeletal troponin T isoforms: correlation with altered Ca2+ regulation associated with development. , 2005, Journal of molecular biology.

[27]  C. J. Duncan,et al.  A model for Duchenne muscular dystrophy ? The action of cytochalasin B on mouse soleus muscle , 1994 .

[28]  P Halonen,et al.  [Facioscapulohumeral muscular dystrophy]. , 1990, Duodecim; laaketieteellinen aikakauskirja.